CN1238807A - 稳定的瞬时基因表达 - Google Patents

稳定的瞬时基因表达 Download PDF

Info

Publication number
CN1238807A
CN1238807A CN97180186A CN97180186A CN1238807A CN 1238807 A CN1238807 A CN 1238807A CN 97180186 A CN97180186 A CN 97180186A CN 97180186 A CN97180186 A CN 97180186A CN 1238807 A CN1238807 A CN 1238807A
Authority
CN
China
Prior art keywords
cell
reagent
acid
dna
transient expression
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN97180186A
Other languages
English (en)
Chinese (zh)
Inventor
R·A·高夫
A·S·高夫
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Genespan Corp
Original Assignee
Genespan Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Genespan Corp filed Critical Genespan Corp
Publication of CN1238807A publication Critical patent/CN1238807A/zh
Pending legal-status Critical Current

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7135—Compounds containing heavy metals
    • A61K31/714—Cobalamins, e.g. cyanocobalamin, i.e. vitamin B12
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/131—Amines acyclic
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/136—Amines having aromatic rings, e.g. ketamine, nortriptyline having the amino group directly attached to the aromatic ring, e.g. benzeneamine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/192—Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid 
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid, pantothenic acid
    • A61K31/198—Alpha-aminoacids, e.g. alanine, edetic acids [EDTA]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/205—Amine addition salts of organic acids; Inner quaternary ammonium salts, e.g. betaine, carnitine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4164—1,3-Diazoles
    • A61K31/4172—Imidazole-alkanecarboxylic acids, e.g. histidine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/87—Introduction of foreign genetic material using processes not otherwise provided for, e.g. co-transformation

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Molecular Biology (AREA)
  • Plant Pathology (AREA)
  • Biophysics (AREA)
  • Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Emergency Medicine (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
CN97180186A 1996-11-01 1997-10-31 稳定的瞬时基因表达 Pending CN1238807A (zh)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US3010996P 1996-11-01 1996-11-01
US60/030,109 1996-11-01
US83374797A 1997-04-11 1997-04-11
US08/833,747 1997-04-11

Publications (1)

Publication Number Publication Date
CN1238807A true CN1238807A (zh) 1999-12-15

Family

ID=26705677

Family Applications (1)

Application Number Title Priority Date Filing Date
CN97180186A Pending CN1238807A (zh) 1996-11-01 1997-10-31 稳定的瞬时基因表达

Country Status (6)

Country Link
EP (1) EP0941356A2 (fr)
JP (1) JP2000509998A (fr)
CN (1) CN1238807A (fr)
AU (1) AU732445B2 (fr)
CA (1) CA2270137A1 (fr)
WO (1) WO1998020146A2 (fr)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102533722A (zh) * 2010-12-24 2012-07-04 北京义翘神州生物技术有限公司 一种通过温度突变提高哺乳动物细胞重组蛋白瞬时表达的方法
CN106811483A (zh) * 2017-02-16 2017-06-09 甘肃农业大学 一种高效转染真核细胞的方法

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4036784A1 (de) * 1990-11-17 1992-05-21 Behringwerke Ag Antivirale aktivitaet des vom adeno-assoziierten virus typ 2 codierten rep-gens
ATE302854T1 (de) * 1993-01-26 2005-09-15 Univ Pennsylvania Zusammensetzungen und verfahren zur verabreichung von genetischem material
US5739118A (en) * 1994-04-01 1998-04-14 Apollon, Inc. Compositions and methods for delivery of genetic material
DK0815257T3 (da) * 1995-01-31 2002-04-22 Bioimage As Fremgangsmåde til karakterisering af biologisk aktive stoffer

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102533722A (zh) * 2010-12-24 2012-07-04 北京义翘神州生物技术有限公司 一种通过温度突变提高哺乳动物细胞重组蛋白瞬时表达的方法
CN102533722B (zh) * 2010-12-24 2014-03-12 北京义翘神州生物技术有限公司 一种通过温度突变提高哺乳动物细胞重组蛋白瞬时表达的方法
CN106811483A (zh) * 2017-02-16 2017-06-09 甘肃农业大学 一种高效转染真核细胞的方法
CN106811483B (zh) * 2017-02-16 2020-04-07 甘肃农业大学 一种高效转染真核细胞的方法

Also Published As

Publication number Publication date
AU732445B2 (en) 2001-04-26
WO1998020146A2 (fr) 1998-05-14
EP0941356A2 (fr) 1999-09-15
JP2000509998A (ja) 2000-08-08
WO1998020146A3 (fr) 1998-08-20
CA2270137A1 (fr) 1998-05-14
AU5160198A (en) 1998-05-29

Similar Documents

Publication Publication Date Title
US20230272346A1 (en) Compositions and methods for increasing the culture density of a cellular biomass within a cultivation infrastructure
CN1271992C (zh) 作为遗传物质转移系统的阳离子病毒体
CN103930542A (zh) 棕色脂肪细胞组合物及方法
CN1728946A (zh) 获得活的人肝细胞,包括肝干/祖细胞的方法
CN1071333A (zh) 钙受体活性分子
CN1174512A (zh) 蛋氨酸酶在抗蛋氨酸和抗高半胱氨酸的化学治疗中的应用
CN1270630A (zh) 处理白细胞的方法、白细胞组合物及其应用方法
CN1084564A (zh) 反义多核苷酸
CN102864171B (zh) 特异促进肝细胞cyp3a4基因高表达的慢病毒表达载体及其构建方法与应用
CN1306569A (zh) 稳定化的瞬时基因表达
CN102766654A (zh) 特异促进肝细胞cyp1a2基因高表达的慢病毒表达载体及其构建方法与应用
Salzman Animal Cell Cultures: Tissue culture is a powerful tool in the study of nutrition, physiology, virology, and genetics.
CN102876716B (zh) 特异促进肝细胞cyp2e1基因高表达的慢病毒表达载体及其构建方法与应用
CN105039251A (zh) 一种pH值稳定的淋巴细胞无血清培养基及其制备方法和应用
CN1238807A (zh) 稳定的瞬时基因表达
Marzullo Regulation of cartilage enzymes in cultured chondrocytes and the effect of 5-bromodeoxyuridine
CN105695400A (zh) 一种纯化干细胞来源的心肌细胞的无血清培养基
CN104164404A (zh) 一种高效的体外培养人脐带间质干细胞的无血清培养体系的用途
CN103243094B (zh) 布莱凯特黑牛pdss1基因单核苷酸多态性及其检测方法
CN1686566A (zh) Cark基因在制备治疗心肌肥厚药物中的应用及一种抑制心肌肥厚的药物
CN109321574A (zh) 抑制ILT5表达的短发卡shRNA、慢病毒及其应用
CN1668339A (zh) 类固醇缀合物、其制剂及其用途
Bachelet et al. Co-culture of mast cells with fibroblasts: a tool to study their crosstalk
CN1242749C (zh) CoCl2在制备治疗白血病的药物中的应用
CN1949979A (zh) 用于改变生物细胞内多聚不饱和脂肪酸含量的组合物及方法

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C02 Deemed withdrawal of patent application after publication (patent law 2001)
WD01 Invention patent application deemed withdrawn after publication